Skip to content

Circles

C

Clearmind Medicine Inc.

CMND· Nasdaq

C

CMNDClearmind Medicine Inc.

CMNDClearmind Medicine Inc.·Earnings record

Q3 2024

Source filing unavailable

Previous · Q2 2024 Next · Q4 2024

Q3 2024 · —

Revenue—

Net Income

-$2.09M

derivedno prior Q3 2023 on file

EPS Diluted

-$0.59

no prior Q3 2023 on file

Operating Cash Flowderived-$1,126,741—

Same quarter

no prior Q3 2023 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’24 Q2 ’24Q3 ’24Q4 ’24^d Q1 ’25 Q2 ’25 Q3 ’25 Q4 ’25^d Q1 ’26

Clearmind Medicine Inc. · CIK 1892500 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy